Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
115.9 USD | -0.10% |
|
+4.56% | -6.65% |
03:28pm | Leerink Adjusts Price Target on DexCom to $151 From $161 | MT |
07-15 | Morgan Stanley Cuts Price Target on DexCom to $120 From $132, Keeps Equalweight Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.65% | 46.16B | |
-4.50% | 179B | |
-2.60% | 100B | |
+18.16% | 44.81B | |
+9.87% | 44.38B | |
+14.08% | 29.53B | |
+22.31% | 25.83B | |
-7.19% | 23.97B | |
+3.64% | 22.5B | |
-9.08% | 22.11B |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- Transcript : DexCom, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 08